BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36075007)

  • 1. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study.
    de Baat EC; Feijen EAM; Reulen RC; Allodji RS; Bagnasco F; Bardi E; Belle FN; Byrne J; van Dalen EC; Debiche G; Diallo I; Grabow D; Hjorth L; Jankovic M; Kuehni CE; Levitt G; Llanas D; Loonen J; Zaletel LZ; Maule MM; Miligi L; van der Pal HJH; Ronckers CM; Sacerdote C; Skinner R; Jakab Z; Veres C; Haddy N; Winter DL; de Vathaire F; Hawkins MM; Kremer LCM
    J Clin Oncol; 2023 Jan; 41(1):96-106. PubMed ID: 36075007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer.
    Mansouri I; Allodji RS; Hill C; El-Fayech C; Pein F; Diallo S; Schwartz B; Vu-Bezin G; Veres C; Souchard V; Dumas A; Bolle S; Thomas-Teinturier C; Pacquement H; Munzer M; Bondiau PY; Berchery D; Fresneau B; Oberlin O; Diallo I; De Vathaire F; Haddy N
    Eur J Heart Fail; 2019 Apr; 21(4):509-518. PubMed ID: 30592114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
    van Nimwegen FA; Ntentas G; Darby SC; Schaapveld M; Hauptmann M; Lugtenburg PJ; Janus CPM; Daniels L; van Leeuwen FE; Cutter DJ; Aleman BMP
    Blood; 2017 Apr; 129(16):2257-2265. PubMed ID: 28143884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure after treatment for breast cancer.
    Boekel NB; Duane FK; Jacobse JN; Hauptmann M; Schaapveld M; Sonke GS; Gietema JA; Hooning MJ; Seynaeve CM; Maas AHEM; Darby SC; Aleman BMP; Taylor CW; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):366-374. PubMed ID: 31721395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure.
    Armenian SH; Hudson MM; Chen MH; Colan SD; Lindenfeld L; Mills G; Siyahian A; Gelehrter S; Dang H; Hein W; Green DM; Robison LL; Wong FL; Douglas PS; Bhatia S
    BMC Cardiovasc Disord; 2016 Oct; 16(1):187. PubMed ID: 27716152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study.
    Shrestha S; Bates JE; Liu Q; Smith SA; Oeffinger KC; Chow EJ; Gupta AC; Owens CA; Constine LS; Hoppe BS; Leisenring WM; Qiao Y; Weathers RE; Court LE; Pinnix CC; Kry SF; Mulrooney DA; Armstrong GT; Yasui Y; Howell RM
    Radiother Oncol; 2021 Oct; 163():199-208. PubMed ID: 34454975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer.
    Ehrhardt MJ; Ward ZJ; Liu Q; Chaudhry A; Nohria A; Border W; Fulbright JM; Mulrooney DA; Oeffinger KC; Nathan PC; Leisenring WM; Constine LS; Gibson TM; Chow EJ; Howell RM; Robison LL; Armstrong GT; Hudson MM; Diller L; Yasui Y; Armenian SH; Yeh JM
    J Clin Oncol; 2020 Nov; 38(33):3851-3862. PubMed ID: 32795226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
    Bates JE; Shrestha S; Liu Q; Smith SA; Mulrooney DA; Leisenring W; Gibson T; Robison LL; Chow EJ; Oeffinger KC; Armstrong GT; Constine LS; Hoppe BS; Lee C; Yasui Y; Howell RM
    J Clin Oncol; 2023 Aug; 41(22):3826-3838. PubMed ID: 37307512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study.
    Veiga LH; Curtis RE; Morton LM; Withrow DR; Howell RM; Smith SA; Weathers RE; Oeffinger KC; Moskowitz CS; Henderson TO; Arnold MA; Gibson TM; Leisenring WM; Neglia JP; Turcotte LM; Whitton JA; Robison LL; Armstrong GT; Inskip PD; Berrington de Gonzalez A
    JAMA Pediatr; 2019 Dec; 173(12):1171-1179. PubMed ID: 31657853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study.
    Bates JE; Howell RM; Liu Q; Yasui Y; Mulrooney DA; Dhakal S; Smith SA; Leisenring WM; Indelicato DJ; Gibson TM; Armstrong GT; Oeffinger KC; Constine LS
    J Clin Oncol; 2019 May; 37(13):1090-1101. PubMed ID: 30860946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Association Study Identifies
    Wang X; Singh P; Zhou L; Sharafeldin N; Landier W; Hageman L; Burridge P; Yasui Y; Sapkota Y; Blanco JG; Oeffinger KC; Hudson MM; Chow EJ; Armenian SH; Neglia JP; Ritchey AK; Hawkins DS; Ginsberg JP; Robison LL; Armstrong GT; Bhatia S
    J Clin Oncol; 2023 Mar; 41(9):1758-1769. PubMed ID: 36508697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
    Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
    J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.
    Henderson TO; Rajaraman P; Stovall M; Constine LS; Olive A; Smith SA; Mertens A; Meadows A; Neglia JP; Hammond S; Whitton J; Inskip PD; Robison LL; Diller L
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):224-30. PubMed ID: 22795729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study.
    Feijen EAML; Font-Gonzalez A; Van der Pal HJH; Kok WEM; Geskus RB; Ronckers CM; Bresters D; van Dalen EC; van Dulmen-den Broeder E; van den Berg MH; van der Heiden-van der Loo M; van den Heuvel-Eibrink MM; van Leeuwen FE; Loonen JJ; Neggers SJCMM; Versluys ABB; Tissing WJE; Kremer LCM;
    J Am Heart Assoc; 2019 Jan; 8(1):e009122. PubMed ID: 30595059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative Absolute Risk of Subsequent Colorectal Cancer After Abdominopelvic Radiotherapy Among Childhood Cancer Survivors: A PanCareSurFup Study.
    Heymer EJ; Jóźwiak K; Kremer LC; Winter DL; de Vathaire F; Sunguc C; Sugden E; Kok JL; van der Pal HJH; Hjorth L; Jakab Z; Maule MM; Haupt R; Bagnasco F; Terenziani M; Diallo I; Gunnes MW; Sommer G; Zadravec Zaletel L; Kuehni CE; Winther JF; Lähteenmäki PM; Gudmundsdottir T; Allodji RS; Skinner R; Ronckers CM; Hawkins MM; Reulen RC; Teepen JC
    J Clin Oncol; 2024 Jan; 42(3):336-347. PubMed ID: 37972325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
    Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
    J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.
    van Dalen EC; van der Pal HJ; van den Bos C; Kok WE; Caron HN; Kremer LC
    Eur J Cancer; 2006 Oct; 42(15):2549-53. PubMed ID: 16919450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study.
    Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH;
    J Natl Cancer Inst; 2012 Sep; 104(17):1293-305. PubMed ID: 22949432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.